1Berendt M J, North RJ. T-cell-mediated suppression of anti-tumor immunity. An explanation forprogressive growth of an immuno- genic tumor. J Exp Med, 1980, 151(1): 69-80.
2Ikeda H, Chamoto K, Tsuji T, et al. The critical role of type-1 innate and acquired immunity in tumor immunutherapy. Cancer Science, 2004, 95: 697-703.
3Garcia-Suarez J, Krsnik I, Reyes E, et al. Elderly haematologi- cal patients with chemotheray-induced febrile neutropenia have similar rates of infection and outcome to younger aduhs:a prospective study of risk-adapted therapy. Br J Haematol, 2003, 120(2): 209-216.
4Hong C, Lee H, Oh M, et al. CD4+ cells in the absence of the CD8+ cytotoxic T cells arc critical and sufficient for NKT cell-depen- dent tumor rejection. ] Immunol, 2006, 177(10): 6747-6757.
5Bursuker I, North RJ. Generati6n and decay of the immune response to a progerssive fibrosarcoma failure to demonstrate pos-texcision immunity after the onset of T cell-mediated sup- pression of immunity. J Exp Med, 1984, 159(5): 1312-1321.
